Avicanna Inc (TSE:AVCN) has released an update.
Avicanna Inc., a biopharmaceutical company specializing in cannabinoid-based products, has successfully completed a non-brokered private placement, raising approximately $2.125 million through the sale of over 5 million units at $0.40 each. The company’s CEO expressed gratitude to shareholders and optimism about using the funds to achieve self-sufficiency and advance their commercial and expansion strategies. The funds are earmarked for capital purposes, production, and research, with each unit consisting of a share and a half warrant, exercisable at $0.55 until 2027.
For further insights into TSE:AVCN stock, check out TipRanks’ Stock Analysis page.
